Amgen · 1 day ago
Oncology Strategy Senior Manager
US - Massachusetts - Cambridge
Full-time
Onsite
Mid, Senior Level
$161K/yr - $188K/yr
4+ years expAmgen is a biotechnology company focused on serving patients living with serious illnesses. In this role, you will lead strategic initiatives within the Oncology Therapeutic Area, focusing on R&D topics and managing cross-functional teams to develop and synthesize complex strategies.
BiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Lead strategic initiatives that shape Amgen’s Oncology Therapeutic Area future, focusing on topics in the R&D space
Commission projects by Development leadership and require independent leadership of a cross-functional team
Influence and communicate effectively with portfolio analytics, executive presentations, and workshop facilitation/synthesis
Work within cross-functional teams, including collaborators inside and outside R&D verticals with an aptitude for project management
Handle ambiguity, open-scope projects, and ad hoc projects/requests
Conduct annual oncology therapeutic area strategy; modality strategy deep dives, AI strategy support, and updates of Amgen’s portfolio strategy and pipeline
Qualification
Required
Doctorate degree and 2 years of business strategy experience
Master's degree and 4 years of business strategy experience
Bachelor's degree and 6 years of business strategy experience
Associate's degree and 10 years of business strategy experience
High school diploma / GED and 12 years of business strategy experience
Management consulting experience, extending into external landscaping, preclinical deep dives, and cross-functional case development
Strong communicator (oral and written)
Comfortable with portfolio analytics, executive presentations, and workshop facilitation/synthesis
Ability to work within cross-functional teams, including collaborators both inside and outside R&D verticals
Aptitude for project management
Comfortable with ambiguity, open-scope projects, and ad hoc projects/requests
Strong scientific background with direct oncology knowledge
Preferred
MD, MBA, MS, Ph.D or equivalent
Six or more years of strategy experience within management consulting, finance, or corporate strategy functions
Oncology R&D experience in the biopharmaceutical industry (biotech, pharmaceutical company)
In-depth understanding of and success in how to conceptualize, design, and synthesize complex topics for a broad audience
Understanding of trends in Artificial Intelligence and applicable use cases in R&D
Finance competence and ability to perform NPV analysis, spend categorization, business case, etc
Robust knowledge of biopharma industry (i.e., pharma development, translational sciences, R&D processes)
Understanding of interplay among various partners in the industry, awareness of trends and recent developments, and ability to research / learn/ synthesize findings on new topics
Excellent cross-functional communication skills and a decisive yet affiliative leadership style to drive results while maintaining relationships
Benefits
A comprehensive employee benefits package, including a Retirement and Savings Plan with generous company contributions, group medical, dental and vision coverage, life and disability insurance, and flexible spending accounts
A discretionary annual bonus program, or for field sales representatives, a sales-based incentive plan
Stock-based long-term incentives
Award-winning time-off plans
Flexible work models where possible.
Company
Amgen
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
10001+ employees
H1B Sponsorship
Amgen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (429)
2024 (485)
2023 (485)
2022 (540)
2021 (460)
2020 (444)
Funding
Current Stage
Public CompanyTotal Funding
$28.5B2022-12-12Post Ipo Debt· $28.5B
1983-06-17IPO
Leadership Team
Robert Bradway
Chairman and Chief Executive Officer
Jay Bradner
Executive Vice President of R&D, and Chief Scientific Officer
Recent News
2026-01-07
Pharma Letter
2026-01-07
bloomberglaw.com
2026-01-07
Company data provided by crunchbase